Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Not Confirmed
Not Confirmed
23-25 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Industry Trade Show
Not Confirmed
23-25 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-bayer-takeda-pfizer-downsize-to-combat-cost-pressures-meet-restructuring-plans
24 Jul 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/07/25/2918498/0/en/Vidac-Pharma-publishes-results-of-next-generation-drug-candidate-tests-in-human-and-murine-tumor-models.html
03 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/03/2891897/0/en/Vidac-Pharma-receives-US-patent-office-Notice-of-Allowance-for-crucial-compounds-in-its-cancer-drug-candidates.html
27 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/03/27/2852896/0/en/Vidac-Pharma-receives-Japanese-Patent-Office-Notice-of-Allowance-for-VDA-1275-cancer-drug-candidate.html
12 Mar 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/03/12/2844278/0/en/Vidac-Pharma-secures-approval-for-next-phase-of-clinical-study-of-lead-asset-in-Cutaneous-T-Cell-Lymphoma.html
19 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/19/2831055/0/en/Vidac-Pharma-presents-high-efficacy-in-multiple-solid-tumor-models-for-its-next-generation-cancer-drug-candidate-and-synergy-with-standard-of-care-treatment-in-liver-cancer-organoi.html
29 Jan 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/01/29/2818489/0/en/Vidac-Pharma-reports-positive-interim-Phase-2a-data-in-orphan-disease-cutaneous-T-cell-lymphoma-CTCL-with-lead-asset-VDA-1102.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?